# PT-141 Dosage for Men: How Providers Decide Off-Label

**By TelosRX Editorial Team** · 2026-10-11

**There is no FDA-approved PT-141 dosage for men. Bremelanotide is approved only as Vyleesi, for premenopausal women with low sexual desire, so any PT-141 dosage for men is an off-label decision a licensed provider makes from small early-phase studies, the approved label and your own health history. Blood pressure, heart history and other medications shape that decision more than any number on a forum.**

That is why searches for "pt141 dosage" turn up such different figures. This guide explains how the decision is actually made for men, what the male research tested, and which safety factors can rule PT-141 out. Nothing below is a dose to follow.

## Why PT-141 dosage for men starts from a women's label

PT-141 is the research name for bremelanotide, a melanocortin receptor agonist that acts at MC3R and MC4R receptors in the brain. It is not a blood-flow drug and does not work like Viagra or Cialis. The mechanism difference is covered in [PT-141 vs Viagra and Cialis](https://www.telosrx.com/blogs/peptides/pt-141-vs-viagra-cialis).

In 2019 the FDA approved Vyleesi, a 1.75 mg bremelanotide autoinjector, for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. The [Vyleesi prescribing information](https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210557s000lbl.pdf) states plainly that it is not indicated for men, and not indicated to enhance sexual performance.

So the only fully characterised dose was studied in a different population, and the male data come from earlier, smaller trials. Using PT-141 in men is **off-label**: legal and common in medicine, but it means the provider is reasoning from indirect evidence rather than reading an approved instruction for your situation.

## What the approved label says, and why it is only a reference point

These are the published parameters for the approved product. They describe Vyleesi in its approved population. They are not instructions for compounded PT-141 or for men.

| Vyleesi label item | What it states | Why it matters to a provider treating a man |
| --- | --- | --- |
| **Dose and route** | 1.75 mg, subcutaneous, as needed | The only dose studied at phase 3 scale, but in women, not men |
| **Timing** | At least 45 minutes before anticipated activity | A central mechanism takes time; the optimal window was not fully characterised |
| **Frequency ceiling** | No more than 1 dose in 24 hours; more than 8 doses a month not recommended | Tied to blood pressure and pigmentation findings, which apply regardless of sex |
| **Contraindications** | Uncontrolled hypertension or known cardiovascular disease | A hard screening line, and the one most relevant to many men |

Compounded PT-141 is not FDA-approved and has no approved strength or schedule. The provider decides whether to prescribe it, how much and how often. For the label in full detail, see the [PT-141 dosage guide](https://www.telosrx.com/blogs/peptides/pt-141-dosage-guide).

## What the male PT-141 studies actually tested

The male research is early-phase, small and developer-sponsored. Here is what three of those studies describe.

-   **Intranasal PT-141 in men (2004).** A double-blind, placebo-controlled study in healthy men and men with mild to moderate erectile dysfunction reported dose-dependent drug levels and an erectile response at the higher doses tested, with first response at around 30 minutes. Flushing and nausea were the most common side effects ([Diamond et al., 2004](https://pubmed.ncbi.nlm.nih.gov/14963471/)).
-   **Subcutaneous PT-141 in men (2004).** Healthy men received single doses across a wide range in a dose-finding design, and a separate group of men who had an inadequate response to Viagra received two dose levels versus placebo. Both studies reported a statistically significant erectile response ([Rosen et al., 2004](https://pubmed.ncbi.nlm.nih.gov/14999221/)).
-   **PT-141 with sildenafil (2005).** A crossover study in 19 men combined low doses of intranasal PT-141 and sildenafil and reported a greater response than sildenafil alone, without new adverse events in that small group ([Diamond et al., 2005](https://pubmed.ncbi.nlm.nih.gov/15833522/)).

What these studies did not do matters just as much. They were signal-finding work, mostly single sessions in a clinic. Much of it used the nasal route, which was later dropped because of blood pressure findings. There was never a phase 3 program in men, and none of these papers produced an approved male dose. The wider evidence picture lives in [PT-141 for men: what the research shows](https://www.telosrx.com/blogs/peptides/pt-141-for-men-research-guide).

This is why a pt-141 dosage copied from a paper or forum does not transfer to you: different route, setting or population, in people who had already been screened.

Want a licensed provider to look at your blood pressure, heart history and medications before anything is decided? The online visit is short, reviewed without a scheduled appointment, and you pay nothing if you are not approved.

[See if PT-141 is right for you](https://www.telosrx.com/pages/lp7pt141)

## How a provider sets the dose and timing for a man

Because the decision is off-label, a provider is not filling in a pre-approved box. They are answering a sequence of questions, roughly in this order.

1.  **Is the concern desire, mechanics, or both?** PT-141 acts on desire and arousal pathways in the brain, so faded interest is a closer fit than a pure blood-flow problem.
2.  **Is PT-141 safe for this person at all?** Blood pressure, cardiovascular history and current medications come before any discussion of amount.
3.  **What starting amount fits the risk picture?** The provider weighs the approved label, the male research and your history. A cautious starting point is common when evidence is indirect.
4.  **How should it be timed?** PT-141 is an as-needed medicine, given ahead of anticipated activity, not a daily one. The label's "at least 45 minutes" reflects a central mechanism that takes time to build.
5.  **How often is too often?** Frequency limits exist because of blood pressure and pigmentation, and they apply to men too.
6.  **What happens next?** Side effects such as nausea or flushing, and how you respond, are reported back so the plan can be adjusted, paused or stopped.

Most of these steps are about safety, which is why the provider, not the patient, sets the numbers.

## Safety factors that change the PT-141 decision for men

### Blood pressure

The Vyleesi label reports that each dose transiently raises blood pressure and lowers heart rate. In studies, peak increases were up to 6 mmHg systolic and 3 mmHg diastolic, peaking 2 to 4 hours after the dose and usually returning to baseline within 12 hours. The label says to ensure blood pressure is well controlled before starting. Uncontrolled hypertension is a contraindication, so a provider may ask for a recent reading before deciding anything.

### Cardiovascular history

Known cardiovascular disease is also a contraindication, and the label says bremelanotide is not recommended for people at high risk of it. For men, this is often the deciding factor: a history of heart attack, angina, stroke or heart failure generally ends the conversation about PT-141 rather than changing the dose.

### PDE5 inhibitors and nitrates

Many men asking about PT-141 already use, or have tried, a PDE5 inhibitor such as sildenafil or tadalafil. The only combination data come from the small 2005 study above, so a provider will want to know exactly what you take and how often. Nitrates, the chest-pain medicines such as nitroglycerin, are a separate red flag. [MedlinePlus](https://medlineplus.gov/druginfo/meds/a699015.html) lists nitrates among the medicines that should not be taken with sildenafil, and needing nitrates usually signals the kind of heart disease that rules bremelanotide out.

### Other medications

The label notes that bremelanotide may slow gastric emptying, affecting some oral medicines, and may substantially reduce exposure to oral naltrexone. The full list is in [PT-141 drug interactions](https://www.telosrx.com/blogs/peptides/pt-141-drug-interactions).

### Side-effect tolerance

In the 52-week open-label extension of the phase 3 program, the most common treatment-related effects were nausea (40.4%), flushing (20.6%) and headache (12.0%) ([Simon et al., 2019](https://pubmed.ncbi.nlm.nih.gov/31599847/)). Those were women, but flushing and nausea were also the most common effects in the male studies. Focal hyperpigmentation has been reported with repeated dosing. More detail sits in [PT-141 side effects and safety](https://www.telosrx.com/blogs/peptides/pt-141-side-effects-safety).

## PT 141 peptide for men: why "research" vials skew the dosage question

A lot of pt141 for men content online comes from sellers of "research use only" vials, with no prescriber and no way to confirm strength, so any number is meaningless when you cannot be sure what is in the vial. How to tell a legitimate prescription path from that market is covered in our sibling guide, [how to buy PT-141 online safely](https://www.telosrx.com/blogs/peptides/buy-pt-141-online-safely).

## How telos rx approaches PT-141 for men

telos rx prescribes compounded PT-141 as a small as-needed subcutaneous injection, given at home before anticipated activity. There is no nasal spray. You can see the details on the [PT-141 page](https://www.telosrx.com/pages/pt-141).

-   **One online intake** for adults of any sex, covering blood pressure, heart history, medications and goals.
-   **Asynchronous review** by a licensed provider, without a scheduled appointment. Every prescription is subject to medical approval by a licensed provider, and you pay nothing if you are not approved.
-   **Provider-set dosing and timing.** Use in men is off-label, and the provider decides whether, how much and how often.
-   **Licensed US partner pharmacies**, free discreet shipping, FSA/HSA eligible, cancel anytime.

Plans are as low as $138 per month. telos rx is LegitScript-certified. Compounded PT-141 is not FDA-approved. Unsure if you are a candidate? Read [who should not take PT-141](https://www.telosrx.com/blogs/glp1/pt-141-who-should-not-take-it).

## Frequently asked questions

### What is the PT-141 dosage for men?

There is no FDA-approved PT-141 dosage for men. Bremelanotide is approved only as Vyleesi for premenopausal women with HSDD, so use in men is off-label. A licensed provider decides whether to prescribe it and sets the amount and timing based on the label, early male studies and your health history.

### Is PT-141 FDA-approved for men?

No. The Vyleesi label states it is not indicated for men. Compounded PT-141 is separately not FDA-approved and has not been evaluated by the FDA for safety, effectiveness or quality.

### What doses did the male PT-141 studies use?

Early studies in men tested a range of single doses, by nasal spray and by injection, mostly in a clinic setting. They were small, early-phase studies designed to find a signal and check tolerability. None produced an approved male dose, so their numbers are not instructions for anyone.

### Can men with high blood pressure use PT-141?

Bremelanotide transiently raises blood pressure after each dose, and the label lists uncontrolled hypertension and known cardiovascular disease as contraindications. A provider reviews your blood pressure and heart history before deciding, and for some men the answer is no.

### Can PT-141 be taken with Viagra or Cialis?

Only a small 2005 study looked at PT-141 combined with sildenafil. Any combination is a decision for a licensed provider who knows all your medications. Nitrates are a separate concern, because they should not be taken with sildenafil and usually point to heart disease.

### Who decides my PT-141 dose and timing?

A licensed provider does, after reviewing your online intake. At telos rx that review is asynchronous, and every prescription is subject to medical approval by a licensed provider. Do not copy doses from forums, papers or seller charts.

Skip the guesswork on dosing. Start a short online visit and a licensed provider will decide whether PT-141 fits your health history, and if so, how it should be used.

[Start your online visit](https://www.telosrx.com/pages/lp7pt141)

_This article is for general education and is not medical advice. Compounded PT-141 is not FDA-approved and has not been evaluated by the FDA for safety, effectiveness or quality. Use of bremelanotide in men is off-label. All prescriptions are subject to medical approval by a licensed provider; approval is not guaranteed. Individual experiences vary. telos rx is an online-first, asynchronous telehealth service and is LegitScript-certified. Medications are filled by licensed US partner pharmacies._

**Tags:** Bremelanotide, Men's Health, PT-141, PT-141 Dosage, Sexual Health

---

> Source: [Telos RX](https://www.telosrx.com/blogs/peptides/pt-141-dosage-for-men)
